Phase 4 Asthma Trial, Recruiting (NCT05114096)

Phase 4 Asthma Trial, Recruiting NCT05114096 Sponsor: McMaster University Condition: Asthma

Printed from Voxsanity (voxsanity.com.au) — NCT05114096 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Asthma

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are pregnant, between 18 and 55 years old, and are carrying one baby or twins
Your pregnancy is between 22 weeks and 0 days and 34 weeks and 6 days along, and you are considered at risk of giving birth early
You have received only one dose of a medication called Celestone (a steroid shot) within the last 24 hours
You are able to understand and sign a written consent form

Who may not be able to join:

You have a medical reason why you cannot take corticosteroid medications (steroid medicines)
You have been taking steroid medications during this pregnancy to manage an ongoing health condition, such as lupus, severe asthma, or COVID-19
You have taken part in this same trial during a previous pregnancy
You or your baby has a known serious or life-threatening condition, such as a significant birth defect or chromosomal problem (confirm with trial site)
One or more of your babies has passed away after 14 weeks of pregnancy

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Sarah D McDonald, MD,MSc,FRCSC, McMaster University

Phone: 905-525-9140

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05114096

Sponsor: McMaster University

Phase: Phase 4

Status: Recruiting

Condition: Asthma

Trial contact: 905-525-9140

More information: https://clinicaltrials.gov/study/NCT05114096

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are pregnant, between 18 and 55 years old, and are carrying one baby or twins
Your pregnancy is between 22 weeks and 0 days and 34 weeks and 6 days along, and you are considered at risk of giving birth early
You have received only one dose of a medication called Celestone (a steroid shot) within the last 24 hours
You are able to understand and sign a written consent form

Who may not be able to join:

You have a medical reason why you cannot take corticosteroid medications (steroid medicines)
You have been taking steroid medications during this pregnancy to manage an ongoing health condition, such as lupus, severe asthma, or COVID-19
You have taken part in this same trial during a previous pregnancy
You or your baby has a known serious or life-threatening condition, such as a significant birth defect or chromosomal problem (confirm with trial site)
One or more of your babies has passed away after 14 weeks of pregnancy

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 4

Sponsor

McMaster University

Registry

ClinicalTrials.gov

Start date

20 July 2023

Est. completion

31 December 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Perinatal Mortality or Substantial Neonatal Morbidity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov